How to buy ChromaDex Corporation stock

ChromaDex Corporation is a biotechnology business based in the US. ChromaDex Corporation shares (CDXC) are listed on the NASDAQ and all prices are listed in US Dollars. ChromaDex Corporation employs 110 staff and has a trailing 12-month revenue of around USD$56.9 million.

How to buy shares in ChromaDex Corporation

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for ChromaDex Corporation. Find the stock by name or ticker symbol: CDXC. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until ChromaDex Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of ChromaDex Corporation, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of ChromaDex Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced traders

Interactive Brokers

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active traders. We picked Interactive Brokers for this category because it offers advanced tools and low fees for active investors and pros. The simpler IBKR Lite platform is aimed at less-active investors, but all users older than 21 must meet a $20,000 liquid net worth requirement for a cash account.

What's in this guide?

1. CDXC shares summary
2. Compare share dealing platforms
3. Is CDXC stock a buy or sell?
4. Stock performance over time
5. Can I short CDXC shares?
6. ChromaDex Corporation's financials
7. How volatile are CDXC shares?
8. Does ChromaDex Corporation pay a dividend?
9. Have CDXC shares ever split?
10. Other common questions

ChromaDex Corporation share price

Use our graph to track the performance of CDXC stocks over time.

ChromaDex Corporation shares at a glance

• Key figures

Information last updated 2021-02-23.

52-week range	USD$2.5 - USD$9.99
50-day moving average	USD$5.3991
200-day moving average	USD$4.9581
Wall St. target price	USD$7.9
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.595

Buy ChromaDex Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Moomoo		$0 for US stocks	Stocks, Options, ETFs	$0		N/A	Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ChromaDex Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of ChromaDex Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting ChromaDex Corporation shares

There are currently 2.4 million ChromaDex Corporation shares held short by investors – that's known as ChromaDex Corporation's "short interest". This figure is 4.5% down from 2.5 million last month.

There are a few different ways that this level of interest in shorting ChromaDex Corporation shares can be evaluated.

ChromaDex Corporation's "short interest ratio" (SIR)

ChromaDex Corporation's "short interest ratio" (SIR) is the quantity of ChromaDex Corporation shares currently shorted divided by the average quantity of ChromaDex Corporation shares traded daily (recently around 289152.46098439). ChromaDex Corporation's SIR currently stands at 8.33. In other words for every 100,000 ChromaDex Corporation shares traded daily on the market, roughly 8330 shares are currently held short.

However ChromaDex Corporation's short interest can also be evaluated against the total number of ChromaDex Corporation shares, or, against the total number of tradable ChromaDex Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ChromaDex Corporation's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 ChromaDex Corporation shares in existence, roughly 40 shares are currently held short) or 0.0468% of the tradable shares (for every 100,000 tradable ChromaDex Corporation shares, roughly 47 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against ChromaDex Corporation.

Find out more about how you can short ChromaDex Corporation stock.

Have ChromaDex Corporation's shares ever split?

ChromaDex Corporation's shares were split on a 1:3 basis on 13 April 2016. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ChromaDex Corporation shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for ChromaDex Corporation shares which in turn could have impacted ChromaDex Corporation's share price.

ChromaDex Corporation share price volatility

Over the last 12 months, ChromaDex Corporation's shares have ranged in value from as little as $2.5 up to $9.99. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ChromaDex Corporation's is 1.5768. This would suggest that ChromaDex Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

ChromaDex Corporation overview

ChromaDex Corporation operates as a nutraceutical company. The company offers Nicotinamide riboside (NIAGEN), a novel form of vitamin B3 for enhancing nicotinamide adenine dinucleotide (NAD) level used for healthy aging; and Immulina, a spirulina extract and compound, which is used for improving human immune function. It also provides reference standards and fine chemicals to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, and pharmaceutical industries. The company markets and sells its products directly in the United States and Canada; and through international distributors. ChromaDex Corporation is headquartered in Los Angeles, California.

Frequently asked questions

• What percentage of ChromaDex Corporation is owned by insiders or institutions?

  Currently 37.956% of ChromaDex Corporation shares are held by insiders and 25.122% by institutions.

• How many people work for ChromaDex Corporation?

  Latest data suggests 110 work at ChromaDex Corporation.

• When does the fiscal year end for ChromaDex Corporation?

  ChromaDex Corporation's fiscal year ends in December.

• Where is ChromaDex Corporation based?

  ChromaDex Corporation's address is: 10900 Wilshire Boulevard, Los Angeles, CA, United States, 90024

• What is ChromaDex Corporation's ISIN number?

  ChromaDex Corporation's international securities identification number is: US1710774076

• What is ChromaDex Corporation's CUSIP number?

  ChromaDex Corporation's Committee on Uniform Securities Identification Procedures number is: 001627108